Search Results
Results found for "Jonathan F Fay"
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
Robert F. Bruns About Dr. Robert F. Robert F. Bruns on the web ResearchGate LinkedIn Dr.
- Dr. Christel Menet | Dr. GPCR Ecosystem
Christel Menet "I did my Ph.D. in Manchester UK with Prof Jonathan Clayden in organic chemistry.
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
Ben’s research focuses on Smoothened and other class F GPCRs which play essential roles in embryonic
- Dr. Bruno Giros | Dr. GPCR Ecosystem
distinctions, including the CNRS silver medal, the FRM "Young Researcher" prize, the ISI “Highly Cited” and F-
- About Dr. GPCR Podcast | Dr. GPCR Ecosystem
Carrier paths, choosing research topics, switching fields, late start, failures and successes.
- Dr. Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
She thought the experiment had failed.
- University | Dr. GPCR Ecosystem
Fair enough. Here are the concerns we hear most — and honest answers. "It's too expensive."
- Dr. Jennifer Pluznick: Olfactory Receptors in the Kidney and the Gut-Microbe Signal | Dr. GPCR Ecosystem
The trafficking failure itself may encode something about how tightly ORs are regulated in olfactory orthology calls are often ambiguous, and in the Pluznick lab's hands, putative orthologs frequently fail
- Dr. Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Fiona Marshall walks through the decade when membrane proteins kept failing to crystallize in detergent non-orthosteric binding sites on GPCRs Biased agonism, target validation, and animal-to-human translation failure Marshall's caution is hard-won: many animal-model-validated GPCR drugs have failed in the clinic precisely
- Dr. Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
For Aaron, this work is personal: he has built his career hunting greenfield targets where others had failed He looks for target classes where existing platforms have already failed — not because the biology is
- Dr. Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
chronic pain are fundamentally different biological systems than naïve ones, and that drug discovery fails personal — the delta opioid receptor has been her scientific focus for nearly two decades, through failed is that the organism in a chronic disease state is fundamentally altered, and that drug candidates fail After failed trials in depression and pain, Dr.
- Dr. Terry Hébert | Dr. GPCR Ecosystem
Pandemic preparedness as a scientific failure — The gap between what infectious disease researchers had The failure wasn't epistemic — it was institutional. And that failure is what will cost the most, borne hardest by the people least cushioned against it.
- Dr. J. Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
Silvio Gutkind on G protein hotspot mutations, why the canonical GαQ pathway fails in uveal melanoma, The canonical assumption that targeting PLC would be therapeutic has failed in the clinic, and patients 16:45 Why CXCR3 may decide who responds to checkpoint inhibitors 20:28 GαQ, uveal melanoma, and the failure
- Dr. Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
why rotation students act like a sorting hat, and why breakthroughs come from working hypotheses that fail a lab is its physical walls, and how much is the community, the plan, and the willingness to let a failed students as cross-pollinators between labs Why breakthroughs tend to come from working hypotheses that fail Breakthroughs come from working hypotheses that fail. Dr. knowledge in a career 12:20 Rotation students as the sorting hat 13:20 When the working hypothesis fails
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
Streicher trained in signal transduction during his PhD on heart failure and p38 MAP kinase, and moved Attempts to replicate the arrestin-knockout phenotypes on clean mouse backgrounds have failed. Dr. John Streicher 01:49 From heart failure to opioids — a path through signaling 07:49 Why the mu receptor turns out that it was signal transduction, and he worked on the signaling cascades involved in heart failure
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
overcoming fluctuating confidence levels during his PhD journey, emphasizing the importance of viewing failures He highlighted that he had to regain his confidence after a period of three failed experiments.
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
just explain How his team uses structure-based modeling to identify novel GPCR ligands The value of failure—and
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
.” — Alex Serafini Failure & Frustration: From Pipettes to Pandemic Disruption The road hasn’t been smooth He's equally focused on sex differences in pain processing and the failure of "one-size-fits-all" models
- Dr. Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
emphasizes the importance of research environments that allow curiosity, experimentation, and even failure
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
is on pulmonary arterial hypertension, a disease of the pulmonary arterioles that causes right heart failure
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
In this wide-ranging conversation, he reflects on the mentors, failures, and bold questions that shaped What You’ll Learn in This Episode How Ajay’s failed MD/PhD application rerouted his path toward a breakthrough using it to predict signaling bias The entrepreneurial lessons no one tells postdocs: how to pitch, fail That “failure” became a launchpad: Ajay later joined the lab of Dr.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Yamina and Arthur from Monash University discussed Arthur's career journey, the importance of hard work, failure They discussed the value of hard work, failure, and the significance of differentiation in their personal
- GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem
What learning from “failed” screens can reveal about receptor pharmacology and species selectivity.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Yamina and Arthur from Monash University discussed Arthur's career journey, the importance of hard work, failure They discussed the value of hard work, failure, and the significance of differentiation in their personal
- Dr. Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
beta-arrestin simultaneously — far exceeding the simple binary framework that guided a biased agonist into a failed Dichotomy — The AT1 receptor couples to Gq, Gi, G12, and beta-arrestin simultaneously, and the clinical failure A Clinical Trial Failure That Pointed Forward The Trevena biased agonist for the AT1 receptor failed Hebert argues this was not a failure of the concept but of incomplete pharmacological characterization
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
Why peptide-based fluorescent ligands succeeded where antibodies repeatedly failed.
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
Bangalore, India, to investigate the mechanisms behind rare mitochondrial diseases, which can lead to heart failure
- Dr. Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem
Apart from APOE4 in Alzheimer’s disease, most signals failed to reach robustness with available cohort
- From Rare Earth Probes to Internalization Assays: The pHSense Story with Dr. Eric Trinquet | Dr. GPCR Ecosystem
fluorescence chemistry, functional assays, and product development, Eric takes us through the highs, failures A mix of scientific curiosity, a tolerance for failure, and a commitment to delivering real-world impact—one
- Dr. Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
unusually candid about what drug discovery against GPCRs actually requires, why most hypotheses still fail The hypothesis is what fails. about yet 47:13 Why BRET captures what second-messenger assays miss 51:01 Why most GPCR drug hypotheses fail "The reason that so many things fail is not because a chemist didn't do their work, but because the hypothesis





























